Pretreatment neutrophil-to-lymphocyte/monocyte-to-lymphocyte ratio as prognostic biomarkers in glioma patients
Main Authors: | S.T. Chim, P. Sanfilippo, T.J. O'Brien, K.A. Drummond, M. Monif |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Brain and Spine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772529422006257 |
Similar Items
-
Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis
by: Yan Wang, et al.
Published: (2023-12-01) -
Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet−to−Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta−analysis
by: Jiali Leng, et al.
Published: (2022-05-01) -
Effect of Intraoperative Opioid Dose on Perioperative Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Glioma
by: Liu X, et al.
Published: (2024-04-01) -
Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
by: Najjar M, et al.
Published: (2018-01-01) -
Prognostic Significant of Neutrophil: Lymphocyte Ratio, Platelet – Lymphocyte ratio, and Lymphocyte – Monocyte ratio in Kurdish Patients with breast cancer
by: S. Khazaei, et al.
Published: (2022-07-01)